Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596455 | SCV000701995 | pathogenic | not provided | 2016-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001381364 | SCV001579728 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-11-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 497475). This premature translational stop signal has been observed in individual(s) with clinical features of Leber congenital amaurosis (PMID: 20683928). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu146Glyfs*17) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). |
Fulgent Genetics, |
RCV002483577 | SCV002785064 | pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2022-01-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003465333 | SCV004216528 | pathogenic | Bardet-Biedl syndrome 14 | 2024-03-14 | criteria provided, single submitter | clinical testing |